{"id":8340,"date":"2020-11-12T07:00:00","date_gmt":"2020-11-12T07:00:00","guid":{"rendered":"https:\/\/www.acarix.com\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/"},"modified":"2024-11-18T19:05:44","modified_gmt":"2024-11-18T19:05:44","slug":"en-framgangsrik-emission-med-fokus-pa-forsaljning-2","status":"publish","type":"post","link":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/","title":{"rendered":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<div>\n<p class=\"mfn-wp-retain\">Press release (MAR)<\/p>\n<p class=\"mfn-wp-retain\">Malm&ouml;, 12 november, 2020<\/p>\n<p class=\"mfn-wp-retain\"><strong>Acarix AB (publ) publicerar del&aring;rsrapport, januari &ndash; september 2020<\/strong><\/p>\n<p class=\"mfn-wp-retain\"><strong>En framg&aring;ngsrik emission med fokus p&aring; f&ouml;rs&auml;ljning!<\/strong><\/p>\n<p class=\"mfn-wp-retain\">Under tredje kvartalet s&aring;g vi ett &ouml;kat intresse f&ouml;r v&aring;rt anv&auml;ndarv&auml;nliga diagnostiska test. Under kvartalet har vi levererat 14 CADScor&reg;System, vilket &auml;r v&aring;rt b&auml;sta kvartal hittills. Framg&aring;ngen baseras fr&auml;mst p&aring; en stark utveckling i Tyskland, &Ouml;sterrike och Schweiz, men vi mottog ocks&aring; v&aring;ra f&ouml;rsta order i Mellan&ouml;stern vilket bidrog till det positiva resultatet. I kombination med f&ouml;rs&auml;ljning av v&aring;ra eng&aring;ngspl&aring;ster motsvarar detta en betydande oms&auml;ttningstillv&auml;xt j&auml;mf&ouml;rt med samma tid f&ouml;reg&aring;ende &aring;r.<\/p>\n<p class=\"mfn-wp-retain\"><em>Utdrag ur VD Per Perssons kommentar till del&aring;rsrapporten.<\/em><\/p>\n<p class=\"mfn-wp-retain\"><strong>Tredje kvartalet 2020 j&auml;mf&ouml;rt med samma period 2019<\/strong><\/p>\n<ul type=\"disc\">\n<li>Under tredje kvartalet s&aring;ldes 14 (3) CADScor&reg;System och 1&nbsp;320 (496) eng&aring;ngspl&aring;ster till b&aring;de slutf&ouml;rbrukare och distribut&ouml;rer.<\/li>\n<li>Int&auml;kterna uppgick till 791 kSEK (120), med ett bruttoresultat om 552 kSEK (74) och en bruttomarginal om 70 procent (62).<\/li>\n<li>R&ouml;relsekostnaderna uppgick till 9&nbsp;440 kSEK (11&nbsp;401).<\/li>\n<li>Resultat f&ouml;re skatt uppgick till &ndash;8&nbsp;880 kSEK (&ndash;11&nbsp;324).<\/li>\n<li>Kassafl&ouml;det fr&aring;n den l&ouml;pande verksamheten uppgick till &ndash;6&nbsp;418 kSEK (&ndash;11&nbsp;002). Periodens nettokassafl&ouml;de, efter erh&aring;llen emissionslikvid om netto 47&nbsp;536 kSEK, uppgick till 40&nbsp;951 kSEK.<\/li>\n<li>Resultat per aktie uppgick till &ndash;0,11 SEK (&ndash;0,49). Inga utsp&auml;dningseffekter uppkom.<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>F&ouml;rsta nio m&aring;naderna 2020 j&auml;mf&ouml;rt med samma period 2019 <\/strong><\/p>\n<ul type=\"disc\">\n<li>Under de f&ouml;rsta nio m&aring;naderna s&aring;ldes totalt 20 (13) CADScor&reg;System och 2&nbsp;120 (2&nbsp;826, inklusive 1&nbsp;100 s&aring;lda till bolagets kliniska pr&ouml;vningar) eng&aring;ngspl&aring;ster, vilket generade int&auml;kter p&aring; 1&nbsp;204 kSEK (1&nbsp;083) med ett bruttoresultat om 881 kSEK (823), motsvarande en bruttomarginal p&aring; 73 procent (76).<\/li>\n<li>R&ouml;relsekostnaderna uppgick till 30&nbsp;925 kSEK (37&nbsp;283).<\/li>\n<li>Resultat f&ouml;re skatt uppgick till &ndash;30&nbsp;085 kSEK (&ndash;36&nbsp;447).<\/li>\n<li>Kassafl&ouml;det fr&aring;n den l&ouml;pande verksamheten uppgick till &ndash;24&nbsp;141 kSEK (&ndash;36&nbsp;411). Inklusive erh&aring;llen emissionslikvid uppgick periodens nettokassafl&ouml;de till 22&nbsp;698 kSEK (&ndash;37&nbsp;537).<\/li>\n<li>Beh&aring;llning av likvida medel uppgick till 76&nbsp;413 kSEK (27&nbsp;685).<\/li>\n<li>Resultat per aktie uppgick till &ndash;0,49 SEK (&ndash;1,58). Inga utsp&auml;dningseffekter uppkom.<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>H&auml;ndelser under tredje kvartalet 2020<\/strong><\/p>\n<ul type=\"disc\">\n<li>Den 15 juli 2020 meddelade bolaget att styrelsen, under f&ouml;ruts&auml;ttning av extra bolagsst&auml;mmas godk&auml;nnande, beslutat om en garanterad f&ouml;retr&auml;desemission om h&ouml;gst 86&nbsp;156&nbsp;738 aktier som vid full teckning ber&auml;knades tillf&ouml;ra bolaget cirka 56 MSEK f&ouml;re avdrag f&ouml;r kostnader.<\/li>\n<li>Extra bolagsst&auml;mma h&ouml;lls den 11 augusti 2020 f&ouml;r att godk&auml;nna emissionen. Dessutom beslutades att utf&auml;rda 3&nbsp;000&nbsp;000 teckningsoptioner till nyckelpersoner i bolaget.<\/li>\n<li>Den 3 september meddelade f&ouml;retaget att det tyska h&auml;lsoministeriet har tillk&auml;nnagivit att fonokardiografi f&ouml;r att utesluta kransk&auml;rlssjukdomar har potential f&ouml;r allm&auml;n anv&auml;ndning i Tyskland. Den tyska gemensamma federala kommitt&eacute;n (G-BA) har angivit huvuddragen i de grundl&auml;ggande delar en eventuell studie b&ouml;r innefatta. Studien ska utf&ouml;ras av en oberoende vetenskaplig institution och enligt uppsatta riktlinjer fr&aring;n G-BA. &rdquo;V&auml;gledningen fr&aring;n G-BA bekr&auml;ftar det kliniska v&auml;rdet och relevansen av v&aring;r CADScor&reg;-teknik&rdquo;, s&auml;ger Per Persson, VD f&ouml;r Acarix.<\/li>\n<li>Den 11 september tillk&auml;nnagav bolaget att emissionen tecknades till totalt cirka 123 procent och inbringade cirka 56 MSEK f&ouml;re kostnader.<\/li>\n<li>Den 29 september 2020 meddelade bolaget att en riktad nyemission genomf&ouml;rts till de garanter i f&ouml;retr&auml;desemissionen som valt att erh&aring;lla garantiers&auml;ttning i form av nyemitterade aktier.<\/li>\n<\/ul>\n<p class=\"mfn-wp-retain\"><strong>H&auml;ndelser efter den 30 september 2020<\/strong><br \/>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&middot;Den 15 oktober har bolaget ing&aring;tt avtal med Redeye AB avseende tj&auml;nsten som Certified Adviser. Redeye AB tilltr&auml;dde som Certified Adviser den 19 oktober 2020.<\/p>\n<p class=\"mfn-wp-retain\">Den fullst&auml;ndiga del&aring;rsrapporten finns tillg&auml;nglig via l&auml;nk nedan samt p&aring; www.acarix.com<\/p>\n<p class=\"mfn-wp-retain\"><strong>Kontaktpersoner f&ouml;r mer information <\/strong><\/p>\n<p class=\"mfn-wp-retain\">Per Persson, VD <br \/>e-post: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-CL2iYcLU15TeJi6Ihj1JrX2KjVKNasnkDi-WXD15IDuUR_f8g_s1B9pjsQB0zrVCF9kvpirrIf4rlui9OjXA3B3YkbwmBVe88OipytzZxc=\" target=\"_blank\" title=\"\" rel=\"nofollow noopener\"><u>per.persson@acarix.com<\/u><\/a> <br \/>tel: +46 736 005&nbsp;990<\/p>\n<p class=\"mfn-wp-retain\">Christian Lindholm, CFO <br \/>e-post: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CpagOe_Q4jXKaU-YdpiksgYzQamXA0mz4f-kZTmugbGaz98DQogoXGQCi1uJ3rIYhtk94KC2u78L14fzl-k5WrK12U9NMNcNO3n2IMS34rlWHe5-xnMl8MPMJOhyTOAn\" target=\"_blank\" title=\"\" rel=\"nofollow noopener\"><u>christian.lindholm@acarix.com<\/u><\/a><br \/>tel: +46 705 118&nbsp;333<\/p>\n<p class=\"mfn-wp-retain\"><strong>Om Acarix<\/strong><br \/>Acarix grundades 2009 och &auml;r noterat p&aring; Nasdaq First North Premier. Acarix CADScor&reg;System anv&auml;nder en avancerad sensor som placeras p&aring; huden ovanf&ouml;r hj&auml;rtat f&ouml;r att lyssna p&aring; ljudet av hj&auml;rtkontraktion och turbulent fl&ouml;de. Det har utformats f&ouml;r att vara ett allt-i-ett-system i den meningen att signalen fr&aring;n hj&auml;rtat spelas in, bearbetas och visas som en patientspecifik s.k. CAD-score p&aring; sk&auml;rmen. Presentation av m&auml;tresultaten erh&aring;lls p&aring; mindre &auml;n 8 minuter. Som en s&auml;ker metod och l&auml;mplig f&ouml;r anv&auml;ndning i b&aring;de prim&auml;rv&aring;rden och p&aring; inneliggande patienter kan CADScor&reg;System potentiellt komma att spela en viktig roll f&ouml;r patient-triage, n&aring;got som g&ouml;r att m&aring;nga patienter inte beh&ouml;ver unders&ouml;kas ytterligare med invasiva, diagnostiska metoder.<\/p>\n<p class=\"mfn-wp-retain\"><em>Denna <\/em><em>information <\/em><em>&auml;r regulatorisk information som Acarix AB (publ)<\/em> <em>ska offentligg&ouml;ra enligt EU:s marknadsmissbruksf&ouml;rordning.<\/em> <em>Informationen l&auml;mnades f&ouml;r publicering genom ovanst&aring;ende kontaktpersons f&ouml;rsorg den 12 november 2020 kl 08.00.<\/em><\/p>\n<p class=\"mfn-wp-retain\">&nbsp;<\/p>\n<p><\/div>\n<div class=\"mfn-footer mfn-attachment\">\n<p class=\"mfn-wp-retain\"><strong>Bifogade filer<\/strong><\/p>\n<hr>\n<p class=\"mfn-wp-retain\"><a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/efd057e4-caf5-466c-9850-d95994390873\" target=\"_blank\" rel=\"nofollow noopener\">Acarix Del&aring;rsrapport Q3 2020<\/a><br \/><a href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/faca79fd-9ed1-40ab-9b8a-dbe1d877eb99\" target=\"_blank\" rel=\"nofollow noopener\">PM_Acarix_Q3_2020 sv<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment mfn-primary\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/acarix-delarsrapport-q3-2020.pdf?url=https%3A%2F%2Fml-eu.globenewswire.com%2FResource%2FDownload%2Fefd057e4-caf5-466c-9850-d95994390873\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/acarix-delarsrapport-q3-2020.pdf?url=https%3A%2F%2Fml-eu.globenewswire.com%2FResource%2FDownload%2Fefd057e4-caf5-466c-9850-d95994390873&type=jpg\"><\/span>Acarix Del\u00e5rsrapport Q3 2020<\/a><\/div><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/pm_acarix_q3_2020-sv.pdf?url=https%3A%2F%2Fml-eu.globenewswire.com%2FResource%2FDownload%2Ffaca79fd-9ed1-40ab-9b8a-dbe1d877eb99\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/pm_acarix_q3_2020-sv.pdf?url=https%3A%2F%2Fml-eu.globenewswire.com%2FResource%2FDownload%2Ffaca79fd-9ed1-40ab-9b8a-dbe1d877eb99&type=jpg\"><\/span>PM_Acarix_Q3_2020 sv<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Press release (MAR) Malm&ouml;, 12 november, 2020 Acarix AB (publ) publicerar del&aring;rsrapport, januari &ndash; september 2020 En framg&aring;ngsrik emission med<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[157,140,149,139,160,148,155,142],"tags":[],"class_list":["post-8340","post","type-post","status-publish","format-standard","hentry","category-mfn-report-interim","category-mfn-type-ir","category-mfn-regulatory-mar","category-mfn","category-mfn-report-interim-q3","category-mfn-regulatory","category-mfn-report","category-mfn-lang-sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix\" \/>\n<meta property=\"og:description\" content=\"Press release (MAR) Malm&ouml;, 12 november, 2020 Acarix AB (publ) publicerar del&aring;rsrapport, januari &ndash; september 2020 En framg&aring;ngsri\" \/>\n<meta property=\"og:url\" content=\"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Acarix\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-12T07:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-18T19:05:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"673\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"acarix\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"acarix\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\\\/\"},\"author\":{\"name\":\"acarix\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"headline\":\"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!\",\"datePublished\":\"2020-11-12T07:00:00+00:00\",\"dateModified\":\"2024-11-18T19:05:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\\\/\"},\"wordCount\":1020,\"articleSection\":[\"Interim\",\"IR\",\"MAR\",\"News\",\"Q3\",\"Regulatory\",\"Report\",\"Swedish\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\\\/\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\\\/\",\"name\":\"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\"},\"datePublished\":\"2020-11-12T07:00:00+00:00\",\"dateModified\":\"2024-11-18T19:05:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#website\",\"url\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/\",\"name\":\"Acarix\",\"description\":\"CADScor\u00aeSystem\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/#\\\/schema\\\/person\\\/dac8bcb35fc08033de2c787d232971b5\",\"name\":\"acarix\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\\\/\\\/d.ptpl.dev\\\/acarix\\\/wp-content\\\/plugins\\\/userswp\\\/assets\\\/images\\\/no_profile.png\",\"caption\":\"acarix\"},\"sameAs\":[\"https:\\\/\\\/www.acarix.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix","og_description":"Press release (MAR) Malm&ouml;, 12 november, 2020 Acarix AB (publ) publicerar del&aring;rsrapport, januari &ndash; september 2020 En framg&aring;ngsri","og_url":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/","og_site_name":"Acarix","article_published_time":"2020-11-12T07:00:00+00:00","article_modified_time":"2024-11-18T19:05:44+00:00","og_image":[{"width":1200,"height":673,"url":"https:\/\/d.ptpl.dev\/acarix\/wp-content\/uploads\/2026\/02\/Acarix_web_image.webp","type":"image\/webp"}],"author":"acarix","twitter_card":"summary_large_image","twitter_misc":{"Written by":"acarix","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/#article","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/"},"author":{"name":"acarix","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"headline":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!","datePublished":"2020-11-12T07:00:00+00:00","dateModified":"2024-11-18T19:05:44+00:00","mainEntityOfPage":{"@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/"},"wordCount":1020,"articleSection":["Interim","IR","MAR","News","Q3","Regulatory","Report","Swedish"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/","url":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/","name":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning! - Acarix","isPartOf":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#website"},"datePublished":"2020-11-12T07:00:00+00:00","dateModified":"2024-11-18T19:05:44+00:00","author":{"@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5"},"breadcrumb":{"@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/d.ptpl.dev\/acarix\/en-framgangsrik-emission-med-fokus-pa-forsaljning-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/d.ptpl.dev\/acarix\/"},{"@type":"ListItem","position":2,"name":"En framg\u00e5ngsrik emission med fokus p\u00e5 f\u00f6rs\u00e4ljning!"}]},{"@type":"WebSite","@id":"https:\/\/d.ptpl.dev\/acarix\/#website","url":"https:\/\/d.ptpl.dev\/acarix\/","name":"Acarix","description":"CADScor\u00aeSystem","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/d.ptpl.dev\/acarix\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/d.ptpl.dev\/acarix\/#\/schema\/person\/dac8bcb35fc08033de2c787d232971b5","name":"acarix","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","url":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d1673e9c4b856fa2627a73e477d2d10d47c79d882f69fa533eaf7143a571f6f2?s=96&r=g&d=https:\/\/d.ptpl.dev\/acarix\/wp-content\/plugins\/userswp\/assets\/images\/no_profile.png","caption":"acarix"},"sameAs":["https:\/\/www.acarix.com"]}]}},"_links":{"self":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/8340","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/comments?post=8340"}],"version-history":[{"count":0,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/posts\/8340\/revisions"}],"wp:attachment":[{"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/media?parent=8340"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/categories?post=8340"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/d.ptpl.dev\/acarix\/wp-json\/wp\/v2\/tags?post=8340"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}